Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.
If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.
| Class:Id | Summation:6810154 |
|---|---|
| _displayName | As inferred from mouse embryonic stem cells (Kashyap et al. ... |
| _timestamp | 2015-11-15 08:29:53 |
| created | [InstanceEdit:6810152] May, Bruce, 2015-11-15 |
| text | As inferred from mouse embryonic stem cells (Kashyap et al. 2011, Mazzoni et al. 2013) and embryos (Diman et al. 2011) activated by retinoic acid and human fibroblasts and embryonal carcinoma cells, Hoxa3 chromatin is activated by loss of methylation at lysine-27 of histone H3 (H3K27me3, Kashyap et al. 2011, Mazzoni et al. 2013). loss of Polycomb repressive complex (PRC2, Mazzoni et al. 2013), and gain of H3K4me3 (Kashyap et al. 2011). The Mll2 complex methylates H3K4 at Hoxa3 in fibroblasts (Wang et al. 2009). In human cells KDM6A (UTX) binds HOXA3 and participates in the loss of H3K27me3. |
| (summation) | [BlackBoxEvent:6810169] Hoxa3 chromatin is activated [Mus musculus] |
| [Change default viewing format] | |